Literature DB >> 35178281

Development of Antiarrhythmic Therapy-Resistant Ventricular Tachycardia, Ventricular Fibrillation, and Premature Ventricular Contractions in a 15-Year-Old Patient.

Can Yilmaz Yozgat1, Osman Yesilbas2, Akin Iscan3, Ismail Yurtsever4, Hafize Otcu Temur4, Nigar Bayramova5, Gokce Ergun5, Nur Tekin5, Yilmaz Yozgat6.   

Abstract

Sudden cardiac arrest (SCA) is the sudden cessation of regular cardiac activity so that the victim becomes unresponsive, with no signs of circulation and no normal breathing. Asystole, ventricular tachycardia (VT), ventricular fibrillation (VF), and pulseless electrical activity are the underlying rhythm disturbances in the pediatric age group. If appropriate interventions (cardiopulmonary resuscitation-CPR and/or defibrillation or cardioversion) are not performed rapidly, this condition progresses to sudden death. There have not been many reported cases of the approach and treatment of cardiac arrhythmias after SCA. Herein, we would like to report a case of a 15-year-old female patient with dilated cardiomyopathy (DCM) who was admitted to our clinic a year ago, and while her left ventricular systolic functions were improved, SCA suddenly occurred. Since the SCA event occurred in another city, intravenous treatment of amiodarone was done immediately and was switch to continuous infusion dose of amiodarone until the patient arrived at our institution's pediatric intensive care unit (PICU) 3 hours later. During the patient's 20-day PICU hospitalization, she developed pulseless VT and VF from time to time. The patient's pulseless VT and VF attacks were brought under control by the use of a defibrillator and added antiarrhythmic drugs (amiodarone, flecainide, esmolol, and propafenone). Intriguingly, therapy-resistance bigeminy with premature ventricular contractions (PVCs) continued despite all these treatments. The patient did not have adequate blood pressure measured by invasive arterial blood pressure monitoring while having bigeminy PVCs. The intermittent bigeminy PVCs ameliorated rapidly after intermittent boluses of lidocaine. In the end, multiple antiarrhythmic therapies and intermittent bolus lidocaine doses were enough to bring her cardiac arrhythmias after SCA under control. This case illustrates that malign PVC's should be taken very seriously, since they may predispose to the development of VT or VF. Also, this case highlights the importance of close vigilance of arterial pressure tracings of patients with bigeminy PVCs which develop after SCA and should not be accepted as normal. Thieme. All rights reserved.

Entities:  

Keywords:  bigeminy premature ventricular contractions; lidocaine; pediatric intensive care unit; ventricular fibrillation; ventricular tachycardia

Year:  2020        PMID: 35178281      PMCID: PMC8843404          DOI: 10.1055/s-0040-1715851

Source DB:  PubMed          Journal:  J Pediatr Intensive Care        ISSN: 2146-4626


  16 in total

Review 1.  The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review.

Authors:  A D'Ambrosio; G Patti; A Manzoli; G Sinagra; A Di Lenarda; F Silvestri; G Di Sciascio
Journal:  Heart       Date:  2001-05       Impact factor: 5.994

Review 2.  Epidemiology and mechanisms of sudden cardiac death.

Authors:  Douglas P Zipes
Journal:  Can J Cardiol       Date:  2005-05       Impact factor: 5.223

3.  ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology).

Authors:  Alfred E Buxton; Hugh Calkins; David J Callans; John P DiMarco; John D Fisher; H Leon Greene; David E Haines; David L Hayes; Paul A Heidenreich; John M Miller; Athena Poppas; Eric N Prystowsky; Mark H Schoenfeld; Peter J Zimetbaum; David C Goff; Frederick L Grover; David J Malenka; Eric D Peterson; Martha J Radford; Rita F Redberg
Journal:  Circulation       Date:  2006-11-27       Impact factor: 29.690

Review 4.  Surviving out-of-hospital cardiac arrest: just a matter of defibrillators?

Authors:  Alessandro Zorzi; Nicola Gasparetto; Federica Stella; Andrea Bortoluzzi; Luisa Cacciavillani; Cristina Basso
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2014-08       Impact factor: 2.160

5.  Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC).

Authors:  Antonio Pelliccia; Erik Ekker Solberg; Michael Papadakis; Paolo Emilio Adami; Alessandro Biffi; Stefano Caselli; Andrè La Gerche; Josef Niebauer; Axel Pressler; Christian M Schmied; Luis Serratosa; Martin Halle; Frank Van Buuren; Mats Borjesson; Francois Carrè; Nicole M Panhuyzen-Goedkoop; Hein Heidbuchel; Iacopo Olivotto; Domenico Corrado; Gianfranco Sinagra; Sanjay Sharma
Journal:  Eur Heart J       Date:  2019-01-01       Impact factor: 29.983

Review 6.  Update on myocarditis.

Authors:  Ingrid Kindermann; Christine Barth; Felix Mahfoud; Christian Ukena; Matthias Lenski; Ali Yilmaz; Karin Klingel; Reinhard Kandolf; Udo Sechtem; Leslie T Cooper; Michael Böhm
Journal:  J Am Coll Cardiol       Date:  2012-02-28       Impact factor: 24.094

7.  Video-Only Cardiopulmonary Resuscitation Education for High-Risk Families Before Hospital Discharge: A Multicenter Pragmatic Trial.

Authors:  Audrey L Blewer; Mary E Putt; Lance B Becker; Barbara J Riegel; Jiaqi Li; Marion Leary; Judy A Shea; James N Kirkpatrick; Robert A Berg; Vinay M Nadkarni; Peter W Groeneveld; Benjamin S Abella
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2016-10-04

Review 8.  Sudden cardiac death and cardiovascular pathology: from anatomic theater to double helix.

Authors:  Gaetano Thiene
Journal:  Am J Cardiol       Date:  2014-09-26       Impact factor: 2.778

9.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

Review 10.  Inherited cardiomyopathies and sports participation.

Authors:  A Zorzi; A Pelliccia; D Corrado
Journal:  Neth Heart J       Date:  2018-03       Impact factor: 2.380

View more
  1 in total

1.  Effects of Amiodarone and Esmolol for Heart Rate and Cardiovascular Changes.

Authors:  Hao Wang; Fengping Lei; Lei Bai; Anping Zhang
Journal:  Emerg Med Int       Date:  2022-06-27       Impact factor: 1.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.